Pharmacotherapy in the treatment of clostridium difficile: impact on clinical practice
- At: 2017 FIP Congress in Seoul (South Korea)
- Type: Poster
- By: HOLGADO SANCHEZ, Noelia (University of Malta, Department of Pharmacy, Msida, Malta)
- Co-author(s): Noelia Holgado Sanchez: Department of Pharmacy, University of Malta, Msida, Malta
Janis Vella: Department of Pharmacy, University of Malta, Msida, Malta
Christopher Barbara: Department of Pathology, University of Malta, Msida, Malta
Lilian M. Azzopardi: Department of Pharmacy, University of Malta, Msida, Malta
Screening for Clostridium difficile (CDI) is recommended in the presence of diarrhoea and following recent or current antibiotic treatment.
To propose a framework for Clostridium difficile culturing and antibiotic sensitivity testing with standardization of this procedure on the clinical setting, and to identify risk factors for C... The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.